-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
WHY PATIENTS NEED YOU At Pfizer we deliver breakthroughs that change patients' lives. The Systems Biology team plays a vital role in this mission through the identification of therapeutic targets
-
to the clinic Utilize expertise in epigenetic biology to develop innovative strategies for understanding role of epigenetic mechanisms in cancer progression, drug resistance and immune modulation Collaborate with
-
Laboratory Practices (GCLP) requirements. Develop assays or animal models required to support various vaccine projects. Develop tool assets for advancing systems biology group projects including cell models
-
basic discoveries in the field of cancer cell biology into novel therapeutics. The Senior Scientist will work within a collaborative team of motivated and scientifically rigorous scientists to conduct
-
in the field of cancer cell biology into novel therapeutics. The Principal Scientist will work within a collaborative team of motivated and scientifically rigorous scientists to conduct preclinical
-
sciences). Demonstrated scientific productivity (publications, abstracts, etc.). A thorough understanding of Oncology and cancer biology and its relationship to drug development. Experience in functioning
-
development process with particular emphasis on early clinical development. Scientific excellence; possesses deep knowledge of integrated metabolism biology and metabolic diseases such as obesity, diabetes, and
-
development and team leadership for Pfizer Oncology's Scientific Affairs team. QUALIFICATIONS Key requirements PhD in Biology, Chemistry, or other scientific discipline, or equivalent required 10+ years
-
ROLE SUMMARY Specialty I&I Medical Affairs colleagues are experts with a deep knowledge of I&I medicines and the Inflammation & Immunology therapeutic area. I&I physicians and other health care professionals and stakeholders view them as peers, and I&I colleagues as partners. In Specialty I&I...